diet

Cruciferous nutrients: Improve glucose management and fight diabetes

Cruciferous nutrients: Improve glucose management and fight diabetes

Most health-conscious people have probably heard that eating a diet rich in cruciferous vegetables (broccoli, cauliflower, Brussels sprouts, etc) is good for you because they contain powerful phytonutrients that have been repeatedly shown in scientific studies to protect against cancer. So, assuring you consume cruciferous vegetables regularly is simply health-smart.

Something most folks may not know however is that these same cruciferous nutrients, in particular sulforaphanes, can also help us manage our blood glucose levels and prevent type-2 diabetes (DM2). According to new research published in the 14 June 2017 issue of the journal Science Translational Medicine (link below) sulforaphane derived from broccoli defends against DM2 in two ways; one way is the reduction of glucose production in the liver and the other way is to assist with glucose control.

The take away here is simple. Make sure to make cruciferous vegetables part of your regular diet. They contain bioactive nutrients, like sulforaphanes that other fruits and vegetables do not; phytonutrients that protect and support healthy metabolism in many ways.

The NeoLife Scientific Advisory Board has known about the power of cruciferous vegetables for decades. In fact, when we first developed NeoLife Cruciferous Plus in the middle 1990's, it was formulated specifically to deliver a broad spectrum of bioactive, whole food derived cruciferous nutrients, including sulforaphane, to make it easier for health-conscious folks to boost their daily cruciferous nutrient intake. And of course we have powerful evidence pointing to the benefits the product can provide. This new research just give us one more reason why it make sense to be sure about our daily cruciferous intake.

Think about it!

The link is below for those who would like it.

Source: Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes

0 Comments 0 Comments
0 Comments 0 Comments